Literature DB >> 16209527

Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors.

Kirk L Stevens1, David K Jung, Michael J Alberti, Jennifer G Badiang, Gregory E Peckham, Jim M Veal, Mui Cheung, Philip A Harris, Stanley D Chamberlain, Michael R Peel.   

Abstract

[reaction: see text] A convergent synthesis of substituted pyrazolo[1,5-a]pyridines has been achieved either via a regioselective [3 + 2] cycloaddition of N-aminopyridines with alkynes or by thermal cyclization of disubstituted azirines. Subsequent palladium-catalyzed introduction of pyridines or de novo synthesis of pyrimidines affords inhibitors of p38 kinase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209527     DOI: 10.1021/ol0519745

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Fe(II)-catalyzed amination of aromatic C-H bonds via ring opening of 2H-azirines: synthesis of 2,3-disubstituted indoles.

Authors:  Samaresh Jana; Mack D Clements; Barry K Sharp; Nan Zheng
Journal:  Org Lett       Date:  2010-09-03       Impact factor: 6.005

2.  tert-Butyl N-benzyl-N-(4-methyl-2-pyrid-yl)carbamate.

Authors:  Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-31

3.  tert-Butyl N-benzyl-N-[4-(4-fluoro-benzoyl-meth-yl)-2-pyrid-yl]carbamate.

Authors:  Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-31

4.  A novel pyrazolo[1,5-a]pyridine fluorophore and its application to detect pH in cells.

Authors:  Ping Zhang; Huaying Lv; Guiyun Duan; Jian Dong; Yanqing Ge
Journal:  RSC Adv       Date:  2018-08-31       Impact factor: 4.036

5.  Three successive and regiocontroled palladium cross-coupling reactions to easily synthesize novel series of 2,4,6-tris(het)aryl pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.

Authors:  R Belaroussi; A Ejjoummany; A El Hakmaoui; M Akssira; G Guillaumet; S Routier
Journal:  RSC Adv       Date:  2018-01-02       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.